Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 111574 | 143.97 |
09:34 ET | 21547 | 144.88 |
09:36 ET | 19225 | 144.53 |
09:38 ET | 19714 | 143.07 |
09:39 ET | 17799 | 142.71 |
09:41 ET | 15067 | 142.3 |
09:43 ET | 15469 | 142.1358 |
09:45 ET | 35235 | 142.09 |
09:48 ET | 16718 | 142.64 |
09:50 ET | 18086 | 141.74 |
09:52 ET | 29579 | 140.87 |
09:54 ET | 15608 | 141.39 |
09:56 ET | 10407 | 141.425 |
09:57 ET | 21185 | 142.585 |
09:59 ET | 24577 | 142.81 |
10:01 ET | 7693 | 141.77 |
10:03 ET | 7880 | 141.6233 |
10:06 ET | 2618 | 141.51 |
10:08 ET | 11242 | 141.315 |
10:10 ET | 10650 | 141.79 |
10:12 ET | 8221 | 141.725 |
10:14 ET | 12144 | 141.7013 |
10:15 ET | 12847 | 141.7311 |
10:17 ET | 7534 | 141.77 |
10:19 ET | 5070 | 141.805 |
10:21 ET | 28513 | 141.44 |
10:24 ET | 6204 | 141.555 |
10:26 ET | 11796 | 141.38 |
10:28 ET | 8338 | 141.5 |
10:30 ET | 6038 | 141.265 |
10:32 ET | 4433 | 141.175 |
10:33 ET | 14995 | 140.73 |
10:35 ET | 10911 | 140.98 |
10:37 ET | 9337 | 141.12 |
10:39 ET | 8906 | 140.88 |
10:42 ET | 12940 | 140.91 |
10:44 ET | 5441 | 140.89 |
10:46 ET | 15513 | 141.02 |
10:48 ET | 7822 | 141.6079 |
10:50 ET | 7121 | 141.225 |
10:51 ET | 6392 | 141.26 |
10:53 ET | 4418 | 141.29 |
10:55 ET | 4966 | 141.285 |
10:57 ET | 8562 | 141.005 |
11:00 ET | 6431 | 141.04 |
11:02 ET | 11683 | 140.78 |
11:04 ET | 13257 | 141.44 |
11:06 ET | 5260 | 141.15 |
11:08 ET | 13155 | 140.79 |
11:09 ET | 4213 | 140.715 |
11:11 ET | 4632 | 141.22 |
11:13 ET | 10372 | 141.45 |
11:15 ET | 4524 | 141.2 |
11:18 ET | 5259 | 141.25 |
11:20 ET | 6210 | 141.29 |
11:22 ET | 13233 | 141.05 |
11:24 ET | 2810 | 140.85 |
11:26 ET | 2995 | 140.86 |
11:27 ET | 3734 | 141.02 |
11:29 ET | 2845 | 141.05 |
11:31 ET | 9292 | 141.14 |
11:33 ET | 4551 | 140.94 |
11:36 ET | 2180 | 141.13 |
11:38 ET | 5387 | 141.11 |
11:40 ET | 3677 | 141.27 |
11:42 ET | 5016 | 141.06 |
11:44 ET | 2355 | 141.34 |
11:45 ET | 5489 | 141.22 |
11:47 ET | 19084 | 140.83 |
11:49 ET | 39435 | 141.025 |
11:51 ET | 35665 | 141.275 |
11:54 ET | 7737 | 141.44 |
11:56 ET | 2861 | 141.235 |
11:58 ET | 9926 | 140.8 |
12:00 ET | 13073 | 140.66 |
12:02 ET | 53033 | 139.92 |
12:03 ET | 7065 | 140.1199 |
12:05 ET | 4079 | 140.24 |
12:07 ET | 8737 | 140.31 |
12:09 ET | 5971 | 140.205 |
12:12 ET | 9974 | 140.045 |
12:14 ET | 4758 | 140.3 |
12:16 ET | 15691 | 139.84 |
12:18 ET | 23411 | 139.77 |
12:20 ET | 3466 | 139.76 |
12:21 ET | 12282 | 139.76 |
12:23 ET | 2410 | 139.765 |
12:25 ET | 5211 | 139.66 |
12:27 ET | 20348 | 139.295 |
12:30 ET | 11001 | 139.395 |
12:32 ET | 6848 | 139.43 |
12:34 ET | 14873 | 139.288 |
12:36 ET | 4607 | 139.29 |
12:38 ET | 8358 | 139.355 |
12:39 ET | 6577 | 139.45 |
12:41 ET | 7263 | 139.39 |
12:43 ET | 5579 | 139.575 |
12:45 ET | 9230 | 139.305 |
12:48 ET | 12723 | 139.0299 |
12:50 ET | 8935 | 138.84 |
12:52 ET | 6349 | 138.74 |
12:54 ET | 41556 | 138.27 |
12:56 ET | 15639 | 138.435 |
12:57 ET | 9084 | 138.56 |
12:59 ET | 18863 | 138.76 |
01:01 ET | 10499 | 138.63 |
01:03 ET | 15217 | 138.63 |
01:06 ET | 5684 | 138.65 |
01:08 ET | 8243 | 138.81 |
01:10 ET | 11361 | 138.76 |
01:12 ET | 8012 | 138.81 |
01:14 ET | 18121 | 139.1 |
01:15 ET | 10447 | 139 |
01:17 ET | 8622 | 139.1399 |
01:19 ET | 1103 | 139.075 |
01:21 ET | 11530 | 138.5276 |
01:24 ET | 5864 | 138.623 |
01:26 ET | 2068 | 138.76 |
01:28 ET | 1508 | 138.952 |
01:30 ET | 4212 | 139.13 |
01:32 ET | 12167 | 139.17 |
01:33 ET | 5686 | 139.2 |
01:35 ET | 4180 | 138.95 |
01:37 ET | 1844 | 138.81 |
01:39 ET | 2606 | 138.82 |
01:42 ET | 4611 | 138.8555 |
01:44 ET | 3486 | 138.86 |
01:46 ET | 6844 | 138.94 |
01:48 ET | 1044 | 139.0803 |
01:50 ET | 3942 | 139.02 |
01:51 ET | 4610 | 139.175 |
01:53 ET | 4077 | 138.92 |
01:55 ET | 4928 | 138.995 |
01:57 ET | 8013 | 138.9119 |
02:00 ET | 1788 | 138.93 |
02:02 ET | 2934 | 138.905 |
02:04 ET | 16982 | 138.565 |
02:06 ET | 19840 | 138.8 |
02:08 ET | 3470 | 138.91 |
02:09 ET | 3252 | 138.85 |
02:11 ET | 5517 | 139.1 |
02:13 ET | 2480 | 139.29 |
02:15 ET | 13543 | 138.83 |
02:18 ET | 10676 | 138.83 |
02:20 ET | 19887 | 138.48 |
02:22 ET | 7087 | 138.27 |
02:24 ET | 12248 | 138.49 |
02:26 ET | 3597 | 138.62 |
02:27 ET | 3389 | 138.69 |
02:29 ET | 16559 | 138.68 |
02:31 ET | 2695 | 138.86 |
02:33 ET | 11536 | 138.64 |
02:36 ET | 5350 | 138.77 |
02:38 ET | 3883 | 138.93 |
02:40 ET | 9748 | 138.63 |
02:42 ET | 6950 | 138.88 |
02:44 ET | 4977 | 139 |
02:45 ET | 4740 | 139.1992 |
02:47 ET | 5533 | 139 |
02:49 ET | 3500 | 139.285 |
02:51 ET | 4440 | 139.295 |
02:54 ET | 7674 | 139.07 |
02:56 ET | 1929 | 139.2175 |
02:58 ET | 3449 | 139.32 |
03:00 ET | 3068 | 139.395 |
03:02 ET | 2560 | 139.32 |
03:03 ET | 1809 | 139.5 |
03:05 ET | 10933 | 139.33 |
03:07 ET | 2861 | 139.37 |
03:09 ET | 8882 | 139.43 |
03:12 ET | 9637 | 139.8064 |
03:14 ET | 6922 | 139.73 |
03:16 ET | 6970 | 139.81 |
03:18 ET | 6103 | 139.83 |
03:20 ET | 19610 | 139.984 |
03:21 ET | 23876 | 139.99 |
03:23 ET | 4159 | 139.98 |
03:25 ET | 7673 | 139.9 |
03:27 ET | 8548 | 139.78 |
03:30 ET | 2287 | 139.84 |
03:32 ET | 16461 | 139.88 |
03:34 ET | 5737 | 139.95 |
03:36 ET | 19022 | 140.425 |
03:38 ET | 9807 | 140.46 |
03:39 ET | 11435 | 140.67 |
03:41 ET | 30877 | 140.29 |
03:43 ET | 9647 | 140.41 |
03:45 ET | 12457 | 140.03 |
03:48 ET | 12822 | 139.907 |
03:50 ET | 16784 | 139.88 |
03:52 ET | 30290 | 140.015 |
03:54 ET | 29111 | 139.53 |
03:56 ET | 37033 | 139.98 |
03:57 ET | 38611 | 139.97 |
03:59 ET | 51762 | 140.03 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 55.7B | -8.9x | --- |
ICON PLC | 26.3B | 38.0x | +4.68% |
Biogen Inc | 34.0B | 28.9x | -18.14% |
Biontech SE | 22.8B | 180.9x | --- |
Grifols SA | 6.1B | 23.3x | --- |
Incyte Corp | 14.1B | 18.9x | +39.11% |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $53.7B |
---|---|
Revenue (TTM) | $5.2B |
Shares Outstanding | 383.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.69 |
EPS | $-15.66 |
Book Value | $36.27 |
P/E Ratio | -8.9x |
Price/Sales (TTM) | 10.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -99.73% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.